Investor · Seattle, WA
Eagle Point Global Management, LP
Open Eagle in the network graph →Capital
$3.9M
across filings
Active
Nov 2017
to Feb 2021
Most-connected co-filers (47)
Eagle Point Global Management GP, LLC · Seattle, WA11 sharedMark F. Van Coeverden De Groot · TORONTO, Ontario, Canada9 sharedJeffrey Harrell · San Jose, CA7 sharedBernard Rudnick · Newark, DE5 sharedAndrew Luber · Newark, DE5 sharedGavin Davies · St. Peter Port, Y75 sharedMark Leventhal · Melville, NY5 sharedJihan Bowes-Little · West Hollywood, CA5 sharedDavid Copperwaite · St. Peter Port, Y75 sharedDavid Kopans · Arlington, MA5 sharedOliver Morris · St. Helier, Y95 sharedBenjamin Lynett · Austin, TX4 sharedBalaji Bakthavatchalam · San Jose, CA4 sharedStephen Tiller · New York, NY4 sharedGregory J. Smith · New York, NY4 sharedPatrick W. Lin · New York, NY4 sharedTom Frinzi · Costa Mesa, CA4 sharedBrian P. Cassidy · New York, NY4 sharedDean Butler · Costa Mesa, CA4 sharedJ. Andy Corley · Costa Mesa, CA4 sharedSteve T. Kirby · Costa Mesa, CA4 sharedDavis Corley · Costa Mesa, CA4 sharedDaniel Perales · Costa Mesa, CA4 sharedVirgil W. Thompson · Hanover, MD4 shared Recent filings (11)
Processa Pharmaceuticals, Inc.Feb 2021 · 25 co-filers$10.2MeyeBrain Medical, Inc.Mar 2020 · 22 co-filers$24.0MeyeBrain Medical, Inc.Dec 2019 · 20 co-filers$24.0MEagle Point Global Management Fund, LPNov 2019 · 5 co-filerseyeBrain Medical, Inc.Aug 2019 · 13 co-filers$24.0MEagle Point Global Management Fund, LPNov 2018 · 5 co-filersProcessa Pharmaceuticals, Inc.May 2018 · 19 co-filers$8.0MeyeBrain Medical, Inc.Dec 2017 · 20 co-filers$14.0MProcessa Pharmaceuticals, Inc.Dec 2017 · 11 co-filers$2.6MProcessa Pharmaceuticals, Inc.Dec 2017 · 11 co-filers$2.6MeyeBrain Medical, Inc.Nov 2017 · 17 co-filers$14.0M Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Eagle in the interactive graph →